Skip to main content
Premium Trial:

Request an Annual Quote

GenoMed Collaborates with Malaysian Company to Get Edge in Asian Market

NEW YORK, Oct. 24 (GenomeWeb News) - St. Louis, Mo.-based GenoMed announced today that it was collaborating with Kuala Lumpur, Malaysia-based PhenoMed to distribute its products and services in Asia.

 

"We hope that PhenoMed will open the doors to additional highly desirable partnerships in Asia, such as with pharmaceutical companies, clinical diagnostic laboratories, physician and patient groups, national health ministries, etc." GenoMed's CEO David Moskowitz said in a statement.

 

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.